Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Your search for Fortini returned no results
Showing 31 to 45 of 103 results for forming

  1. Pre-hospital initiation of fluid replacement therapy in trauma (TA74)

    Evidence-based recommendations on giving intravenous (IV) fluid replacement therapy for people with serious injuries before reaching hospital.

    Technology appraisal guidance
    Published
    28 January 2004
    View recommendations

    Sections for TA74

  2. Insertion of customised titanium implants, with soft tissue cover, for orofacial reconstruction (HTG307)

    Evidence-based recommendations on insertion of customised titanium implants, with soft tissue cover, for orofacial reconstruction. This involves inserting titanium implants to replace broken bones in the face as part of orofacial reconstruction.

    HealthTech guidance
    Last updated
    1 July 2013
    View recommendations

    Sections for HTG307

  3. Targeted muscle reinnervation for managing limb amputation pain (HTG750)

    Evidence-based recommendations on targeted muscle reinnervation for managing limb amputation pain. This involves attaching nerves that were cut during limb amputation to other nerves in nearby muscles.

    HealthTech guidance
    Published
    12 June 2025
    View recommendations

    Sections for HTG750

  4. Service models for withdrawal interventions: What service models are most effective in supporting withdrawal from medicines associated with dependence and withdrawal symptoms?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  5. Cognitive behavioural therapy (CBT) to support withdrawal from benzodiazepines: What is the most effective model of CBT, including timing of CBT, to support withdrawal from benzodiazepines?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  6. Acupuncture to support withdrawal from opioids: What is the clinical and cost effectiveness of acupuncture (including electroacupuncture) as an adjunct to aid withdrawal from opioids?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  7. Multicomponent withdrawal interventions: What are the key components of an effective multicomponent intervention to support dose reduction during withdrawal of opioids?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  8. Withdrawal interventions for gabapentinoids: What are the most clinically and cost-effective strategies or interventions to aid withdrawal of gabapentinoids?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  9. Psychological interventions to support withdrawal: What are the most effective psychological interventions to support withdrawal and help people cope with withdrawal symptoms?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  10. Aids to support withdrawal: What is the effectiveness of equipment, technologies, practical aids and medicine formulations in supporting people to manage dose reductions, compared with usual practice?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  11. Information for family members or carers: What information and support are needed by family members or carers of people having treatment with an opioid, benzodiazepine, Z‑drug, antidepressant or gabapentinoid?

    recommendation for research, see the rationale section on starting a dependence-forming medicine or antidepressant. Full details of the...

    Research recommendation
    Published
    11 May 2022

  12. Converting to a medicine with a different half‑life to aid withdrawal: What is the clinical and cost effectiveness of converting to medicines with a longer half‑life to aid withdrawal from benzodiazepines or antidepressants?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  13. Talimogene laherparepvec for treating unresectable metastatic melanoma (TA410)

    Evidence-based recommendations on talimogene laherparepvec (Imlygic) for treating unresectable metastatic melanoma in adults when systemically administered immunotherapies are not suitable.

    Technology appraisal guidance
    Published
    28 September 2016
    View recommendations

    Sections for TA410

  14. Individual circumstances and the risk of dependence: Do individual circumstances such as social distress, low income or limited access to alternative sources of support lead to an increased risk of problems associated with dependence on prescribed medicines?

    the rationale section on making decisions about prescribing and taking a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  15. System-level factors and the risk of dependence: Do system-level factors, such as training received by prescribers alter the risk of developing problems associated with dependence on prescribed medicines?

    the rationale section on making decisions about prescribing and taking a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022